The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

Bipolar Disorders

Volumn 11, Issue 5, 2009, Pages 453-473

  Tohen, Mauricio ^a,b   Frank, Ellen ^c   Bowden, Charles L ^a   Colom, Francesc ^d   Ghaemi, S Nassir ^e   Yatham, Lakshmi N ^f   Malhi, Gin S ^g   Calabrese, Joseph R ^h   Nolen, Willem A ⁱ   Vieta, Eduard ^d   Kapczinski, Flávio ^j   Goodwin, Guy M ^k   Suppes, Trisha ^l   Sachs, Gary S ^m   Chengappa, K N Roy ^c   Grunze, Heinz ⁿ   Mitchell, Philip B ^o   Kanba, Shigenobu ^p   Berk, Michael ^q  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF SYDNEY   (Australia)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^k WARNEFORD HOSPITAL   (United Kingdom)

^l STANFORD UNIVERSITY   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o UNIVERSITY OF NEW SOUTH WALES   (Australia)

^p KYUSHU UNIVERSITY   (Japan)

^q UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Affective switch; Bipolar disorder; Course and outcome; Functional outome; ISBD; Nomenclature; Predominant polarity; Recovery recurrence; Relapse; Remission; Response

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CONSENSUS DEVELOPMENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE DURATION; FUNCTIONAL ASSESSMENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL SOCIETY; NOMENCLATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; SOCIAL INTERACTION; SYNDROME DELINEATION; TREATMENT RESPONSE;

ADVISORY COMMITTEES; BIPOLAR DISORDER; CONSENSUS; HUMANS; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC;

EID: 67749096067     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00726.x     Document Type: Review

References (91)

1. Rush AJ, Kraemer HC, Sackeim HA et al. Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology 2006; 31: 1841-1853.
2. Tohen M, Bowden C, Calabrese J et al. The International Society of Bipolar Disorders task force on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2008; 10 (Suppl. 1): 1.
3. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-449.
4. Leucht S, Davis JM, Engel RR, Kane JM, Wagenpfeil S. Defining 'response'in antipsychotic drug trials: Recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 2007; 32: 1903-1910.
5. Frank E, Prien RF, Jarrett JB et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Response, remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48: 851-855.
6. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Press, 2000.
7. Tohen M, Zarate CA, Hennen J et al. The McLean-Harvard first-episode mania study: Prediction of recovery and first recurrence. Am J Psychiatry 2003; 160: 2099-2107.
8. Hirschfeld RM, Calabrese J, Frye MA et al. Defining the clinical course of bipolar disorder response, remission, relapse, recurrence, and roughening. Psychopharmacol Bull 2007; 40: 7-14.
9. Martínez-Arán A, Vieta E, Chengappa KNR, Gershon S, Mullen J, Paulsson B. Reporting outcomes in clinical trials for bipolar disorder: A commentary and suggestions for change. Bipolar Disord 2008; 10: 566-579.
10. Yatham L, Vieta E, Berk M, Tohen M. Moving the field forward: The impact of research driven educational initiatives on bipolar patients and providers. Presented at the 3rd Biennial Conference of the International Society of Affective Disorders, Lisbon, Portugal, 3-6, March 2006.
11. Fava M, Evins AE, Dorer DJ, Schoenfeld DA. The problem of the placebo response in clinical trials for psychiatric disorders: Culprits, possible remedies, and a novel study design approach. Psychother Psychosom 2003; 72: 115-127.
12. Rush AJ, Thase ME, Dube S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry 2003; 53: 743-753.
13. Vieta E, Jaeger J. Functional outcome and disability in bipolar disorders: Ongoing research and future directions. Bipolar Disord 2007; 9: 1-2.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
15. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
16. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS). Psychometric properties. Psychol Med 1996; 26: 477-486.
17. Berk M, Malhi GS, Cahill C et al. The Bipolar Depression Rating Scale (BDRS): Its development, validation and utility. Bipolar Disord 2007; 9: 571-579.
18. Young RC, Biggs JT, Ziegler VE, Merger DA. A rating scale for mania. Reliability, validity, sensitivity. Br J Psychiatry 1979; 133: 429-433.
19. Guy W. Clinical global impressions. In: Guy W, ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publ No ADM 76-338). Rockville, MD: National Institute of Mental Health, 1976: 218-222.
20. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962; 10: 790-812.
21. Kendler KS. Major depression and generalized anxiety disorder. Same genes, (partly) different environments-revisited. Br J Psychiatry 1996; 168 (Suppl. 30): 68-75.
22. Endicott J, Spitzer RL. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-844.
23. Lecrubier Y, Sheehan D, Weiller E et al. The MINI International Neuropsychiatric Interview (M.I.N.I.). A short diagnostic structured interview: Reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 224-231.
24. Kroenke K, Spitzer RL, Williams JB. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
25. Rush AJ, Trivedi MH, Ibrahim HM et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR). A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-583.
26. Trivedi MH, Rush AJ, Ibrahim HM et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med 2004; 34: 73-82.
27. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
28. Beck AT, Steer RA, Brown GK. Beck depression inventory (2nd ed. Manual). San Antonio, TX: The Psychological Corporation, 1996.
29. Nierenberg AA, Keefe BR, Leslie VC et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999; 60: 221-225.
30. Carmody T, Rush AJ, Bernstein I et al. The Montgomery Åsberg and the Hamilton Ratings of depression: A comparison of measures. Eur Neuropsychopharmacol 2006; 16: 601-611.
31. Zimmerman M, Chelminski I, Posternak M. A review of studies of the Montgomery-Åsberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol 2004; 19: 1-7.
32. Zimmerman M, Posternak MA, Chelminski I. Defining remission on the Montgomery-Åsberg depression rating scale. J Clin Psychiatry 2004; 65: 163-168.
33. Zimmerman M, Posternak MA, Chelminski I. Implications of using different cut-offs on symptom severity scales to define remission from depression. Int Clin Psychopharmacol 2004; 19: 215-220.
34. Berk M, Ng F, Wang WV et al. The empirical redefinition of the psychometric criteria for remission in bipolar disorder. J Affect Disord 2008; 106: 153-158.
35. Post R, Altshuler LL, Leverich GS et al. Mood switch in bipolar depression: Comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006; 189: 124-131.
36. Frye MA, Grunze H, Suppes T et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007; 164: 1242-1249.
37. Thase ME, Carpenter L, Kupfer DJ, Frank E. Clinical significance of reversed vegetative subtypes of recurrent major depression. Psychopharmacol Bull 1991; 27: 17-22.
38. Chengappa KNR, Hennen J, Baldessarini RJ et al. Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord 2005; 7: 68-76.
39. Keller MB, Lavori PW, Coryell W, Endicott J, Mueller TI. Bipolar I: A five year prospective follow-up. J Nerv Ment Dis 1993; 181: 238-245.
40. Tohen M, Hennen J, Zarate C et al. The McLean/Harvard First Episode Project: Two-year syndromal and functional recovery in 219 cases of major affective disorders with psychotic features. Am J Psychiatry 2000; 157: 220-228.
41. Perlis RH, Ostacher MJ, Patel JK et al. Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163: 217-224.
42. Riso LP, Thase ME, Howland RH, Friedman ES, Simons AD, Tu XM. A prospective test of criteria for response remission relapse recovery and recurrence in patients treated with cognitive behavior therapy. J Affect Disord 1997; 43: 131-142.
43. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania. A four-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47: 1106-1111.
44. Ghaemi SN, Pardo TB, Hsu DJ. Strategies for preventing the recurrence of bipolar disorder. J Clin Psychiatry 2004; 65 (Suppl. 10): 16-23.
45. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd ed. New York: Oxford University Press, 2007.
46. Hartong EG, Moleman P, Goodguin CA, Broekman TG, Nolen WA, LitCar Group. Prophylactic efficacy of lithium versus carbamazepine in treatment-naïve bipolar patients. J Clin Psychiatry 2003; 64: 144-151.
47. Tohen M, Greil W, Calabrese JR et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: A 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005; 162: 1281-1290.
48. Greil W, Ludwig-Mayerhofer W, Erazo N et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Affect Disord 1997; 43: 151-161.
49. Bowden CL, Calabrese JR, McElroy SL et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000; 57: 481-489.
50. Tohen M, Calabrese JR, Sachs GS et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006; 163: 247-256.
51. Calabrese JR, Shelton MD, Rapport DJ et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162: 2152-2161.
52. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400.
53. Calabrese J, Bowden C, Sachs G et al. A placebo-controlled, 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013-1024.
54. Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537.
55. Altshuler LL, Gitlin MJ, Mintz J, Leight KL, Frye MA. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002; 63: 807-811.
56. MacQueen GM, Marriott M, Begin H, Robb J, Joffe RT, Young LT. Subsyndromal symptoms assessed in longitudinal prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord 2003; 5: 349-355.
57. Tohen M, Bowden CL, Calabrese JR et al. Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Br J Psychiatry 2006; 189: 515-519.
58. Torrent C, Martínez-Arán A, Daban C et al. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006; 189: 254-259.
59. Yatham LN, Lecrubier Y, Fieve RR, Davis KH, Harris SD, Krishnan AA. Quality of life in patients with bipolar I depression: Data from 920 patients. Bipolar Disord 2004; 6: 379-385.
60. Marangell LB. The importance of subsyndromal symptoms in bipolar disorder. J Clin Psychiatry 2004; 65 (Suppl. 10): 24-27.
61. Bagby R, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the gold standard become a lead weight? Am J Psychiatry 2004; 161: 2163-2177.
62. Cassidy F, Pieper CF, Carroll BJ. Subtypes of mania determined by grade of membership analysis. Neuropsychopharmacology 2001; 25: 373-383.
63. Dennehy EB, Suppes T, Crismon ML, Toprac M, Carmody TJ, Rush AJ. Development of The Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder. Psychiatry Res 2004; 127: 137-145.
64. Swann CA, Janicak LP, Calabrese RJ et al. Structure of mania: depressive, irritable, and psychotic cluster with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J Affect Dis 2001; 67: 123-132.
65. Kessler R, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Cormorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
66. Bowden C, Singh V, Thompson P et al. Development of the bipolar inventory of symptoms scale. Acta Psychiatr Scand 2007; 116: 189-194.
67. Fagiolini A, Dell'Osso L, Pini S et al. Validity and reliability of a new instrument for assessing mood symptomatology: The Structured Clinical Interview for Mood Spectrum (SCI-MOODS). Int J Methods Psychiatric Res 1999; 8: 71-82.
68. Dell'Osso L, Armani A, Rucci P et al. Measuring mood spectrum. Comparison of interview (SCI-MOODS) and self-report (MOODS-SR) instruments. Compr Psychiatry 2002; 43: 69-73.
69. Miniati M, Rucci P, Frank E et al. Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version. Psychother Psychosom 2009; 78: 116-124.
70. Judd LL, Schettler PJ, Akiskal HS et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/ recurrence. Arch Gen Psychiatry 2008; 65: 386-394.
71. Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord 2006; 93: 13-17.
72. Rosa AR, Andreazza AC, Kunz M et al. Predominant polarity in bipolar disorder: Diagnostic implications. J Affect Disord 2008;107: 45-51.
73. Vieta E, Berk M, Wang W, Colom F, Tohen M, Baldessarini RJ. Predominant previous polarity as an outcome predictor of outcome in a controlled treatment trial for depression in bipolar I disorder patients. J Affect Disord, [E pub ahead of print, 2009 March 24].
74. Osher Y, Yaroslavsky Y, el-Rom R, Belmaker RH. Predominant polarity of bipolar patients in Israel. World J Biol Psychiatry 2000; 1: 187-189.
75. Daban C, Colom F, Sanchez-Moreno J, Garcia-Amador M, Vieta E. Clinical correlates of first-episode polarity in bipolar disorder. Compr Psychiatry 2006; 47: 433-437.
76. Judd LL, Akiskal HS, Schettler PJ et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269.
77. Perlis RH, Delbello MP, Miyahara S et al. Revisiting depressive-prone bipolar disorder: Polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants. Biol Psychiatry 2005; 58: 549-553.
78. Malhi GS, Ivanovski B, Szekeres V, Olley A. Bipolar disorder: It's all in your mind? The neuropsychological profile of a biological disorder. Can J Psychiatry 2004; 49: 813-819.
79. Olley A, Malhi GS, Mitchell P, Batchelor J, Lagopoulos J, Austin M-P. When euthymia is just not good enough: The neuropsychology of bipolar disorder. J Nerv Ment Dis 2005; 193: 323-330.
80. MacQueen GM, Young LT, Joffe RT. A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand 2001; 103: 163-170.
81. Pope M, Dudley R, Scott J. Determinants of social functioning in bipolar disorder. Bipolar Disord 2007; 9: 38-44.
82. Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E, EMBLEM Advisory Board. Functional impairment in patients with mania: Baseline results of the EMBLEM study. Bipolar Disord 2007; 9: 45-52.
83. Morriss R, Scott J, Paykel E, Bentall R, Hayhurst H, Johnson T. Social adjustment based on reported behaviour in bipolar affective disorder. Bipolar Disord 2007; 9: 53-62.
84. Vieta E, Cieza A, Stucki G et al. Developing core sets for persons with bipolar disorder based on the International Classification of Functioning, Disability and Health. Bipolar Disord 2007; 9: 16-24.
85. Czobor P, Jaeger J, Berns SM, Gonzalez C, Loftus S. Neuropsychological symptom dimensions in bipolar disorder and schizophrenia. Bipolar Disord 2007;9: 71-92.
86. Martínez-Arán A, Vieta E, Colom F et al. Cognitive impairment in euthymic bipolar patients: Implications for clinical and functional outcome. Bipolar Disord 2004; 6: 224-232.
87. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell P, Vieta E, Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 2007; 9: 114-125.
88. Martínez-Arán A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: The role of clinical and cognitive factors. Bipolar Disord 2007; 9: 103-113.
89. Rosa AR, Sanchez-Moreno J, Martínez-Arán A et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health 2007; 7: 3-5.
90. Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: A bipolar disorder perspective. J Affect Disord 2007; 100: 279-281.
91. Vieta E, Phillips ML. Deconstructing bipolar disorder: A critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull 2007; 33: 886-892.